๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

In vivo chemoresistance of prostate cancer in metronomic cyclophosphamide therapy

โœ Scribed by Lilja Thoenes; Miriam Hoehn; Roman Kashirin; Manfred Ogris; Georg J. Arnold; Ernst Wagner; Michael Guenther


Publisher
Elsevier
Year
2010
Tongue
English
Weight
582 KB
Volume
73
Category
Article
ISSN
1874-3919

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Novel antivascular efficacy of metronomi
โœ Roberto Benelli; Stefano Monteghirfo; Cecilia Balbi; Paola Barboro; Nicoletta Fe ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 303 KB

## Abstract Tumor growth requires a competent vascular supply and angiogenesis is now considered a potential target for cancer treatment. Chemotherapeutic drugs, and docetaxel in particular, chronically administered using a frequent schedule at low dose (metronomic dosing), can cause potent antiang

Peptide analogs in the therapy of prosta
โœ Andrew V. Schally; Ana Maria Comaru-Schally; Artur Plonowski; Attila Nagy; Gabor ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 190 KB ๐Ÿ‘ 2 views

The use of peptide analogs in the therapy of prostate cancer is reviewed. The preferred primary treatment of advanced androgen-dependent prostate cancer is presently based on the use of depot preparations of LH-RH agonists. This treatment is likewise recommended in patients with rising PSA levels af

Mechanisms of selenium chemoprevention a
โœ Nagalakshmi Nadiminty; Allen C. Gao ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 412 KB ๐Ÿ‘ 1 views

## Abstract Prostate cancer (PC) chemoprevention has generated considerable interest in the last decade and selenium and combinations of selenium have been recognized as one of the most efficacious chemopreventive agents against PC. This review focuses on a discussion of the knowledge hitherto gain

The effect of short-term cyclophosphamid
โœ Kennedy, B. J. ;Kiang, David T. ๐Ÿ“‚ Article ๐Ÿ“… 1975 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 277 KB

## Abstract Stimulation of tumor growth and induced hypercalcemia both may occur during the initiation of estrogen therapy in breast cancer. This study was conducted to determine whether cyclophosphamide (CTX) as an adjuvant to estrogen therapy might (1) prevent induced hypercalcemia or (2) achieve